Resource Library > Medical & Support Services > Antiretroviral Treatment

Topic: Antiretroviral Treatment

Antiretroviral treatment that results in full viral load suppression is clinically beneficial (making it possible to manage HIV as a chronic condition) and significantly reduces the risk of HIV transmission. Federal expert panels now recommend early treatment for anyone living with HIV, and though there are relatively simple regimens available, patients must adhere to them for a lifetime. Monitoring and managing treatment success is a complex task for clinicians. Finally, despite the many advances in recent years, there is still much that is not understood about the long term impact of HIV and HIV medications.

Filter resources by:

Guidelines and Manuals

Webinars and Training

  • National Center for Innovation in HIV Care
    April 2015

    This webinar presents case studies that illustrate clinical challenges in caring for patients eligible for PrEP and discusses controversies regarding PrEP management.

  • AETC National Resource Center
    January 2014

    Clinical education/training resources and patient education materials from the HRSA AETC network.

  • Philadelphia Office of HIV Planning
    November 2012

    This interactive InfoGraphic explains the Treatment Cascade.

  • NASTAD
    January 2012

    Overview of the 340B program and its relationship to ADAP. See also HRSA's 340 Drug Pricing Program webpage. 

  • HRSA HIV/AIDS Bureau
    August 2010

    Clinical debate of the mathematical theory that HIV/AIDS can be eliminated from society if all adults are tested regularly and all infected persons are put on antiretroviral therapy—regardless of CD4 level. 

  • HRSA HIV/AIDS Bureau
    June 2010

    Overview of HIV drug resistance, its role in transmitting resistant HIV virus, and what clients and peers need to know about it. The webcast also includes an overview of the role of HIV biomedical interventions in reducing risk of HIV transmission.

Tools and Job Aids

  • HRSA
    November 2013

    The Common Patient Assistance Program (PAP) Application can be used to apply for any pharmaceutical assistance program (PAP) offered by pharmaceutical companies. 

  • El Rio Community Health Center
    January 2004

    One-pager poses question to client, "How Ready are You for the Challenge of Taking Your HIV Medications Everyday" followed by scale for patient to mark where they self-assess their readiness.

Reports and Best Practices

  • New Mexico AETC and International Association of Providers of AIDS Care (IAPAC)
    January 2012

    AIDS InfoNet provides reliable, non-technical HIV/AIDS treatment information in English, Spanish, and other languages. The primary audience for InfoNet materials includes people living with HIV and their caregivers, especially nurses and other first-line treatment providers.

Websites

  • New York State Department of Health AIDS Institute
    January 2015

    HIV guidelines, quality of care, clinical education, resources, policies and publications.

  • U.S. Department of Health and Human Services (DHHS)
    January 2015

    infoSIDA ofrece acceso a información actualizada en español sobre el tratamiento de la infección por el VIH/SIDA y ensayos clínicos desarrollados específicamente para las comunidades afectadas por dicha infección y para otras comunidades de atención de salud.

  • U.S. Department of Health and Human Services
    August 2014

    AIDSinfo is the official home to all U.S. HIV-related treatment guidelines. The site also includes a HIV/AIDS health topics database and fact sheets on FDA-approved and investigational HIV/AIDS-related drugs, educational materials for consumers and providers, and a clinical trials database.

  • AETC National Resource Center
    January 2014

    Clinician training resources and tools such as pocket guides, wall charts, and patient education fact sheets developed by the HRSA AIDS Education and Training Centers network. Includes comprehensive training slides to accompany HHS guidelines.

  • HRSA
    January 2012

    Information on HRSA's Office of Pharmacy Affairs, which administers the 340b program, which provides drug discounts to certain federal grantees,